Status:
COMPLETED
Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection
Lead Sponsor:
Haiphong University of Medicine and Pharmacy
Conditions:
Neisseria Gonorrhoeae Infection
Chlamydia Trachomatis Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The frequency of Chlamydia trachomatis and Neisseria gonorrhoeae coinfection can vary depending on their individual incidence and prevalence rates.Single-agent therapy with ceftriaxone is the preferre...
Detailed Description
Gonococcal infections, including urethritis, cervicitis, epididymitis, and proctitis, are a significant cause of morbidity among sexually active men and women. The treatment of these sexually transmit...
Eligibility Criteria
Inclusion
- Patient over 18 ages with laboratory-documented uncomplicated Chlamydia trachomatis and Neisseria gonorrhoeae reinfection at any site
Exclusion
- Pregnancy
- Breast feeding
- Hypersensitivity to cephalosporins or penicillins
- significant renal failure or hepatic failure
Key Trial Info
Start Date :
July 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2022
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT05216744
Start Date
July 15 2021
End Date
February 20 2022
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haiphong International Hospital
Haiphong, Vietnam, 18000